| Literature DB >> 20920296 |
Olga Karapanou1, Anastasios Papadimitriou.
Abstract
Menarche is a milestone in a woman's life as it denotes the start of reproductive capacity. Aim of this report is to review the recent developments and the current knowledge in the neuroendocrinology of pubertal onset and the factors, genetic and environmental, that influence menarcheal age. We also review the implications of early or late menarcheal age on a young woman's life.Entities:
Mesh:
Year: 2010 PMID: 20920296 PMCID: PMC2958977 DOI: 10.1186/1477-7827-8-115
Source DB: PubMed Journal: Reprod Biol Endocrinol ISSN: 1477-7827 Impact factor: 5.211
Figure 1Stimulatory (arrow) and inhibitory (blind-ended arrow) effectors of GnRH pulsatile secretion. mTOR (mammalian target of rapamycin)
Age at menarche in various countries around the world1
| Country, Date: Age | |
|---|---|
| Italy 1995:12.0 | India 1998: 12.1 |
| Greece 1999: 12.3 | Hong Kong 1997:12.4 |
| Thailand 1997: 12.5 | USA/NHANES2 2001: 12.5 |
| France 2006: 12.6 | Japan 1992: 12.6 |
| Spain 2002:12.6 | Venezuela 2000: 12.6 |
| Denmark 1998: 13.0 | Finland 1993: 13.0 |
| UK 1993:13.0 | Belgium 1985:13.1 |
| Cameroon 1999: 13.2 | Netherlands 2000: 13.2 |
| South Africa 1990: 13.2 | Sweden 1996: 13.2 |
| Switzerland 1983: 13.4 | Germany 1996: 13.5 |
1Adapted from Ref [38]
2National Health and Nutrition Examination Survey
Health implications of early or late menarcheal age
| Early menarche | Late menarche |
|---|---|
| Abdominal type obesity | Osteoporosis |
| Insulin resistance | Adolescent depression |
| Glucose intolerance | Social anxiety symptoms |
| Cardiovascular risk | |
| Coronary heart disease | |
| Increased bone mineral density | |
| Increased cancer mortality |